Japan, Nov. 17 -- NOVARTIS AG has got intellectual property rights for 'ANTIBODY-CYTOKINE ENGRAFTED PROTEINS AND METHODS OF USE IN TREATMENT OF CANCER.' Other related details are as follows:
Application Number: JP,2023-188444
Category (FI): A61K39/395@N,C12N15/62@Z,C12N15/26,C12N15/13,C07K19/00,C07K16/00,C07K14/55,A61P43/00,121,A61P35/00,A61K47/68,A61K45/00,A61K38/20
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Nov. 2, 2023
Publication Date: Feb. 21, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
